Skip to main content

Table 3 Predictors of the presence of at least one treatment limitation

From: Patients’ treatment limitations as predictive factor for mortality in COVID-19: results from hospitalized patients of a hotspot region for SARS-CoV-2 infections

Predictor b SE OR 95% CI p-value
Sex (female vs. male) − 0.47 0.33 0.63 0.29 1.15 0.129
Age 0.13 0.02 1.14 1.11 1.20 0.001
PAD 0.32 0.79 1.37 0.28 7.54 0.664
Cardiovascular disease − 0.73 0.37 0.48 0.23 0.95 0.033
Obstructive airway disease 0.32 0.47 1.38 0.58 3.42 0.482
Malignant disease 0.71 0.42 2.03 0.97 5.21 0.074
Dementia 2.06 1.16 7.87 3.35 33.5 0.001
CCI 0.17 0.09 1.19 1.02 1.45 0.036
eGFR ≤ 55 (ml/min) 0.95 0.32 2.57 1.43 5.00 0.002
SpO2 ≤ 93% − 0.34 0.33 0.71 0.37 1.34 0.289
Neutrophils ≥ 5 (G/l) 0.11 0.33 1.11 0.58 2.08 0.723
CRP ≥ 7 (mg/dl) − 0.04 0.33 0.96 0.49 1.82 0.894
  1. For cardiovascular disease and obstructive airway disease compare with Table 2. The results shown are based on 439 patients having complete data for all of the predictors included
  2. Bold p-values represent statistical significance (< 0.05)
  3. b Regression coefficient, SE standard error of regression coefficient, OR odds ratio corresponding to the regression coefficient, CI confidence interval of odds ratio, PAD peripheral artery disease, CCI Charlson comorbidity index, eGFR estimated glomerular filtration rate